A period of trial in American apheresis medicine.
Weinstein
R
R
Department of Medicine, St. Elizabeth's Medical Center of Boston, Tufts University School of Medicine, MA 02135, USA. bobbw@massmed.org
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000553:Ambulatory Care / Q000191:economics*; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000628:therapy; D001781:Blood Component Removal / Q000191:economics*; D014487:Centers for Medicare and Medicaid Services, U.S.; D002819:Chorea / Q000628:therapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004311:Double-Blind Method; D019317:Evidence-Based Medicine; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007349:Insurance, Health, Reimbursement / Q000191:economics; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000628:therapy; D009188:Myelitis, Transverse / Q000188:drug therapy / Q000628:therapy; D009771:Obsessive-Compulsive Disorder / Q000628:therapy; D010044:Outpatient Clinics, Hospital / Q000191:economics*; D010951:Plasma Exchange / Q000191:economics*; D016032:Randomized Controlled Trials as Topic; D012051:Reimbursement Mechanisms / Q000458:organization & administration*; D016896:Treatment Outcome; D014481:United States
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone